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Kindlin-2 controls TGF-b signalling and Sox9
expression to regulate chondrogenesis
Chuanyue Wu1,2,*, Hongli Jiao3,*, Yumei Lai3,*, Wei Zheng3, Ka Chen1, Hong Qu1, Weimin Deng3,
Pingping Song3, Ke Zhu3, Huiling Cao2, Deborah L. Galson4, Jie Fan5, Hee-Jeong Im3, Yujie Liu6,
Ju Chen6, Di Chen3 & Guozhi Xiao2,3
The signals that control skeletogenesis are incompletely understood. Here we show that
deleting Kindlin-2 in Prx1-expressing mesenchymal progenitors in mice causes neonatal
lethality, chondrodysplasia and loss of the skull vault. Kindlin-2 ablation reduces chondrocyte
density by decreasing cell proliferation and increasing apoptosis, and disrupts column
formation, thus impairing the formation of the primary ossification center and causing severe
limb shortening. Remarkably, Kindlin-2 localizes to not only focal adhesions, but also to the
nuclei of chondrocytes. Loss of Kindlin-2 reduces, while the overexpression of Kindlin-2
increases, Sox9 expression. Furthermore, the overexpression of Sox9 restores the defects in
chondrogenic differentiation induced by Kindlin-2 deletion in vitro. In addition, Kindlin-2
ablation inhibits TGF-b1-induced Smad2 phosphorylation and chondrocyte differentiation.
Finally, deleting Kindlin-2 in chondrocytes directly impairs chondrocyte functions, resulting in
progressive dwarfism and kyphosis in mice. These studies uncover a previously unrecognized
function for Kindlin-2 and a mechanism for regulation of the chondrocyte differentiation
programme and chondrogenesis.
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I
n vertebrates, the skeleton not only confers morphology, but
also provides essential functions of life, including control of
movements and protection of vital organs. During embryonic
development, the skeleton is formed from mesenchymal
stem cells (MSCs) through two distinct mechanisms—
intramembranous and endochondral ossification. In intramem-
branous ossification, which forms flat bones, including the skull
vault and part of the clavicle, MSCs condense and differentiate
into osteoprogenitors, and later, osteoblasts1. In endochondral
ossification, which forms most of the other bones, including all
long bones and vertebrae, an intermediate cartilaginous template
is first formed through a process that involves MSC condensation,
chondrocyte proliferation, hypertrophy and apoptosis; this is
followed by replacement by bone in the adjacent metaphysis
through multiple steps, including new blood vessel invasion,
osteoclast differentiation and digestion of the calcified cartilage
and osteoblastogenesis from the perichondrial cells and
bone formation2. Endochondral ossification contributes to the
longitudinal growth of the skeleton. A better understanding
of molecular mechanisms controlling skeletogenesis and
homeostasis is critical for the development of new strategies to
treat major skeletal diseases, such as osteoarthritis.
During skeletal development and homeostasis, chondrocyte
differentiation is tightly controlled by key transcription factors, as
well as distinct signalling pathways. Sox9, a transcription factor of
the sex-determining region Y (SRY)-related high mobility group
box family of proteins, is essential for converting MSCs into
chondrocytes and regulates multiple functions of chondrocytes,
such as proliferation, survival, differentiation and hypertrophy3–6.
Sox9 controls chondrocyte differentiation by directly activating
chondrogenic gene expression (for example, type II collagen or
Col2a1)7,8 and through indirect upregulation of Sox5 and
Sox6 (ref. 3), both key transcription factors that regulate
chondrocyte differentiation9. Transforming growth factor-b
(TGF-b) signalling is a fundamental route that controls
multiple properties of chondrocytes and skeletal development
and homeostasis10–18. While the importance of Sox9 and TGF-b
signalling in the chondrocyte differentiation programme is well
documented in the literature, the mechanism of their modulation
during this process is poorly understood.
During skeletal development and homeostasis, bone cells or
their precursors must migrate to appropriate locations and
communicate with their extracellular matrix to form distinct
elements of the skeleton. Kindlins are a family of evolutionarily
conserved cytoplasmic proteins that are emerging as key
regulators of integrin-mediated cell–extracellular matrix adhe-
sion, migration and signalling19–26. In mammals, the Kindlin
family consists of three members, Kindlin-1, -2 and -3, each of
which contains a FERM (F for 4.1 protein, E for ezrin, R for
radixin and M for moesin) domain that is responsible for
interacting with b-integrin cytoplasmic tails. Mutations in the
KINDLIN-1 gene lead to the Kindler syndrome in humans, which
is characterized by skin blistering27,28. Mutations in the
KINDLIN-3 gene impair integrin activation in humans and
result in leukocyte adhesion deficiency-III, severe bleeding,
frequent infections and osteopetrosis29–32. Global inactivation
of Kindlin-2 in mice resulted in early embryonic lethality at E7.5
(ref. 33). Because of this finding, and because there are no human
genetic diseases known to be linked to mutations in the
KINDLIN-2 gene, functions of Kindlin-2 in regulating the
development and homeostasis of specific organs and tissues are
largely unknown.
To determine the roles of Kindlin-2 during skeletogenesis, we
use a conditional knockout strategy to selectively ablate Kindlin-2
expression in two distinct skeletogenic cells at different stages
of skeletal development in mice. We perform comprehensive
analyses of two mouse models in which Kindlin-2 is ablated in
limb and head mesenchymal progenitor cells or chondrocytes.
We demonstrate that conditional ablation of Kindlin-2 in
Prx1-expressing limb and head mesenchymal progenitors in
mice results in neonatal lethality, severe chondrodysplasia and
complete loss of the skull vault. Loss of Kindlin-2 inhibits
chondrocyte proliferation, increases chondrocyte apoptosis and
disrupts the column formation, which together impairs formation
of the primary ossification centre (POC) of the long bones and
results in limb and digit shortening. Thus, Kindlin-2 expression
in mesenchymal progenitors is critical for endochondral
ossification. Kindlin-2 expression is also required for control of
intramembranous ossification, as demonstrated by a complete
loss of the skull vault and severe hypoplastic clavicles in the
mutant mice. Of particular significance, we find that Kindlin-2
localizes to not only focal adhesions, but also to the nuclei of
chondrocytes where it activates Sox9 expression, a master
regulator of chondrogenesis. Overexpression of Sox9 restores
the defects in chondrogenic differentiation induced by Kindlin-2
deletion in vitro. We further demonstrate that Kindlin-2 ablation
inhibits TGF-b1-induced Smad2 phosphorylation and chondro-
cyte differentiation. Finally, deleting Kindlin-2 in chondrocytes
directly impairs chondrocyte functions, resulting in progressive
dwarfism and kyphosis and osteopenic phenotype in mice.
Collectively, our results shed important new light on the
functions of Kindlin-2 and its mode of action in skeletogenesis.
Results
Multiple skeletal abnormalities in Kindlin-2Prx1 cKO mice.
To investigate the potential roles of Kindlin-2 in the
regulation of skeletogenesis, we used Cre-Lox technology to
conditionally delete Kindlin-2 expression in limb and head
mesenchyme. Kindlin-2fl/fl mice, in which exons 5 and 6 of
Kindlin-2 gene are flanked by loxP sites, were generated as
described in Methods (Supplementary Fig. 1). Crossing the
Prx1-Cre transgenic mice34 with the Kindlin-2fl/fl mice generated
Prx1-Cre; Kindlin-2fl/þmice. Further cross-breeding of the
Kindlin-2fl/fl mice with Prx1-Cre; Kindlin-2fl/þmice successfully
produced Prx1-Cre; Kindlin-2fl/fl mice, the limb and head
mesenchyme conditional KO mice (referred to as Kindlin-
2Prx1cKO hereafter). Prx1-Cre mice, in which the 2.4-kb Prx1
(paired-related homeobox gene-1) gene promoter drives Cre
expression in limb and head mesenchyme, have been widely
used34. In these mice, Cre expression first appears at E9.5 in the
forelimb mesenchyme and E10.5 in the hindlimb bud. These mice
also express high levels of Cre protein in the head mesenchyme34.
Quantitative real-time RT-PCR (qPCR) and western blot analyses
revealed that Kindlin-2 expression was dramatically reduced at
both the mRNA and protein levels in Kindlin-2Prx1cKO limbs,
compared with those of Cre-negative Kindlin-2fl/fl limbs (referred
to as WT hereafter; Fig. 1a,b). Notably, loss of Kindlin-2 did not
significantly alter the levels of Kindlin-1 and Kindlin-3 proteins in
limbs (Supplementary Fig. 2). Immunohistochemical staining of
humeral sections of the two genotypes showed high Kindlin-2
expression in WT chondrocytes, which was strikingly reduced in
mutant chondrocytes (Fig. 1c). It is interesting to note that
although Kindlin-2 is known as a cytoplasmic protein located at
focal adhesion sites, it was strongly detected in the nuclei of
chondrocytes (Fig. 1c). Strikingly, all mutant mice (450) died
immediately after birth. As shown in Fig. 1d, all mutants (4100)
displayed a haematoma on top of the head, which grew larger
over time. Alcian blue and alizarin red double staining of
whole-mount skeletons revealed that, although both bone and
cartilage were present, all mutants exhibited multiple striking
skeletal defects (Fig. 1d–g and Supplementary Fig. 3), including:
(1) severe forelimb and hindlimb shortening; (2) impaired digit
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elongation; (3) shortened, broadened and fused sterna;
(4) complete loss of the skull vault, which may have contributed
to the neonatal lethality due to lack of protection of brain tissue
from damage during birth; and (5) severe hypoplasia of the
clavicle, a defect observed in Runx2 haploinsufficiency in mice
and the human disorder cleidocranial dysplasia35,36. Defects
(1)–(3) suggest that Kindlin-2 is essential for endochondral
ossification and defects (4) and (5) demonstrate that Kindlin-2 is
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Figure 1 | Kindlin-2Prx1 cKO mice display multiple striking skeletal abnormalities. (a,b) Quantitative qPCR and western blot analyses. Total RNA or
protein extracts isolated from the indicated tissues of E14.5 Kindlin-2Prx1 cKO (cKO) or Cre-negative Kindlin-2fl/fl (WT) littermates were subjected to qPCR
(a) or western blot analyses (b) for Kindlin-2 expression. FL, forelimb. Kindlin-2 mRNA was normalized to Gapdh mRNA. b-Actin was used as a loading
control. Experiments were repeated three times. *Po0.05, versus WT, Student’s t-test. Results were expressed as mean±s.d. (c) Immunohistochemistry.
Sections of E14.5 WTand Kindlin-2Prx1 cKO humeri were stained with anti-Kindlin-2 antibody or normal IgG. Note: Kindlin-2 protein is strongly detected in
the nuclei of WT chondrocytes, but is dramatically reduced in mutant cells. Scale bar, 40mm. (d) Gross appearance of E14.5–P0 Kindlin-2Prx1 cKO and
WT embryos showing a haematoma on the top of the head of mutants (arrowhead). Scale bar, 0.5 cm. (e) Alizarin red and alcian blue double stain of
E14.5–P0 skeletons. Scale bar, 0.5 cm. (f) Calvaria, FL, hindlimb (HL), sternum and clavicle from E18.5 embryos. Complete loss of the skull vault, shortened
and broadened scapula, long bone and sternum, hypoplastic clavicle, and blocked (FL) or delayed (HL) elongation of distal phalanges are seen in mutants.
Scale bar, 0.5 cm. (g) Quantitative data from F. N¼4, *Po0.05, versus WT, Student’s t-test. Results were expressed as mean±s.d.
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critically involved in the regulation of intramembranous
ossification, which forms the skull vault and part of the clavicle.
Quantitative analyses revealed that the length of all the long
bones (femur, tibia, humerus, radius and ulna) and their
respective bony portions stained red by alizarin red were
significantly reduced in mutants (Po0.05, Student’s t-test;
Fig. 1g). It should be noted that, although there were striking
skeletal phenotypes, the overall body size of the mutants was not
markedly different from that of the WT (Fig. 1d). The Kindlin-2
flox heterozygotes that harbour Prx1-Cre (that is, Prx1-Cre;
Kindlin-2fl/þ ) were viable and fertile and did not show any
marked skeletal phenotypes (Supplementary Fig. 3 and Fig. 1b,c).
Kindlin-2 controls chondrocyte function and POC formation.
In mice, limb mesenchymal condensation occurs at around
E11.5–E12.5 (ref. 37). After condensation, the majority of
mesenchymal progenitor cells become chondrocytes that go
into the proliferation and differentiation programme37. As shown
in Fig. 2a, at E14.5, chondrocytes in the centre of the cartilage
mould of the WT humerus enlarged and formed a highly
organized hypertrophic zone, which was not observed in the
mutant. By E16.5, a POC was formed in the middle of WT, but
not mutant, humeri (Fig. 2a). At E18.5, the POC was partially
formed in the mutant (Fig. 2a). At birth (P0), a significantly
shorter POC was formed in the mutant (Fig. 2a,d). Loss of
Kindlin-2 similarly delayed formation of ossification centres in
digits (Fig. 2f). One major cellular defect in the mutant growth
plate was a dramatic reduction of chondrocyte density starting at
E14.5 and worsening over time (Fig. 2b,e and Supplementary
Fig. 4). Furthermore, loss of Kindlin-2 greatly impacted
chondrocyte size, morphology and organization in the growth
plate. As shown in Fig. 2c and Supplementary Fig. 4, in the
proliferative zone of the WT humeral growth plate, chondrocytes
were discoid and arranged into regular columns, like stacks of
coins, which were parallel to the long axis of the cartilage. In
contrast, mutant chondrocytes were large and spherical, and
failed to form columns (Fig. 2b,c). Instead of forming the highly
organized hypertrophic zone in the middle of long bones, as
found in the WT, the large spherical mutant chondrocytes were
scattered throughout the growth plate (Fig. 2b).
Kindlin-2 deletion reduces chondrocyte proliferation and survival.
As shown in Fig. 3a, at E12.5, mesenchymal condensation
occurred normally and cell density was not reduced in the
mutant limb buds. Results from in vivo BrdU (5-bromo-
2-deoxyuridine) labelling experiments revealed that the
chondrocyte proliferation rate was significantly reduced in the
E14.5 mutant relative to WT growth plates (Fig. 3b,c). Indian
hedgehog (Ihh) is known to play a critical role in the regulation of
chondrocyte proliferation38–41. In situ hybridization of E14.5
humeral sections showed that IhhmRNA expression was detected
in pre-hypertrophic chondrocytes in WT growth plates, but
was markedly reduced in mutant cells (Fig. 3d). Terminal
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)
staining of E14.5 humeral sections of the two genotypes
demonstrated that chondrocyte apoptosis in the proliferative
zone was dramatically increased in mutant growth plates
(Fig. 3e,f). At E16.5, the apoptosis of hypertrophic chondrocytes
was also greatly increased in the mutants (Fig. 3e,f). Note that
basal apoptosis levels were increased in E16.5 compared to E14.5
chondrocytes in both genotypes. Consistent with increased cell
apoptosis, cleaved (active) caspase-3 was upregulated in mutant
chondrocytes compared with that of WT cells (Fig. 3g). Thus,
reduced cell proliferation capacity and accelerated cell death
could be two major reasons for the reduction of chondrocytes in
mutant growth plates.
Kindlin-2 regulates Sox9 gene expression in chondrocytes.
In situ hybridization showed that the mRNA level of Sox9,
a master regulator of chondrogenesis, was reduced in
mutant humeri and digits compared with that of WT (Fig. 4a,b).
Western blot analysis confirmed that Sox9 was reduced at
the protein level in mutant limbs (Fig. 4c). qPCR analysis
showed that the loss of Kindlin-2 reduced Sox9 and its down-
stream target Col2a1 mRNA expression without affecting the
expression of mRNA for cadherin, a molecule required for
mesenchymal chondrogenic condensation10 (Fig. 4d). In contrast,
the adenoviral overexpression of Kindlin-2 in ATDC5
chondrogenic cells increased the levels of Sox9 protein (Fig. 4e)
and mRNA (Fig. 4f) and activated 2.8-kb mouse Sox9 gene
promoter activity in a dose-dependent manner (Fig. 4g).
Interestingly, although Kindlin-2 is widely recognized as a
cytoplasmic protein, it was strongly detected in the nuclei of
primary ribcage chondrocytes, as measured by immuno-
fluorescence staining followed by confocal analysis (Fig. 4h).
Western blot analysis using nuclear and cytoplasmic extracts
showed that Kindlin-2 protein existed in the nuclei of ATDC5
cells (Fig. 4i). The adenoviral overexpression of Sox9 largely
restored the defects in Col2a1, but not Runx2, mRNA expression
(Fig. 4j,k) and chondrogenic nodule formation in micromass
cultures (Fig. 4l).
Loss of Kindlin-2 impairs TGF-b1 signalling. TGF-b signalling
is critical for skeletal development11–14,17,18. We examined
whether the loss of Kindlin-2 in limb mesenchymal progenitor
cells impairs TGF-b1 signalling. The results showed that Smad2
phosphorylation (pSmad2) was reduced in mutant limbs,
compared to that of WT limbs, starting at E12.5 (Fig. 5a).
The levels of total Smad2/3 proteins were not altered by the
loss of Kindin-2 (Fig. 5a). The expression of b1 integrin and
integrin-linked kinase (ILK), both Kindlin-2-interacting
proteins19,20,33,42, were not altered in mutant limbs (Fig. 5a).
Furthermore, the tyrosine phosphorylation of FAK, one of
the key downstream effectors of integrin signalling, was
not significantly altered in E13.5 Kindlin-2Prx1cKO versus WT
limbs (Supplementary Fig. 5). Similarly, the levels of phospho-p38
and total p38 proteins, which belong to non-canonical
TGF-b signalling43, were not affected by the loss of Kindlin-2
(Fig. 5a). The signal for pSmad2, but not total Smad2/3, was
markedly reduced in both chondrocytes and perichondrial
mesenchymal progenitors of mutant limbs (Fig. 5b). Notably,
loss of Kindlin-2 did not reduce Tgf-b1 mRNA expression in
limbs (Fig. 5c). The levels of TGFb R1 and TGFb R2 proteins
were similar in E13.5 Kindlin-2Prx1cKO versus WT limbs or cells
(Supplementary Fig. 6). In vitro studies using primary
mesenchymal progenitors from E12.5 limbs revealed that
Kindlin-2 ablation (Supplementary Fig. 7) significantly impaired
TGF-b1 induction of Smad2 phosphorylation (Fig. 5d,e). The
results from limb micromass cultures showed that Kindlin-2
ablation severely impaired TGF-b1-induced chondrogenic nodule
formation (Fig. 5f). Furthermore, the loss of Kindlin-2
significantly decreased the TGF-b1-induced expression of Sox9,
Col2, Ihh (Indian hedgehog) and Aggrecan without affecting the
levels of Opn (osteopontin) and Alp (alkaline phosphatase)
mRNAs (Fig. 5g), two osteoblast markers. Finally, b1 integrin
activation was significantly reduced in primary limb
mesenchymal progenitor cells lacking Kindlin-2 compared with
that in WT cells (Fig. 5h).
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Kindlin-2Col2a1 cKO mice display dwarfism and kyphosis.
To determine whether Kindlin-2 plays a direct role in
chondrocytes, we conditionally, and selectively, deleted Kindlin-2
in chondrocytes by breeding Col2a1-Cre transgenic mice with
Kindlin-2fl/fl mice to obtain Col2a1-Cre; Kindlin-2fl/fl mice
(referred to as Kindlin-2Col2a1cKO hereafter). Col2a1-Cre
transgenic mice expressing Cre recombinase under the control of
the mouse Col2a1 gene promoter are widely used to efficiently
drive Cre expression in chondrocytes44. Kindlin-2Col2a1 cKO mice
were born at the expected Mendelian frequency. Western blot
analysis showed that Kindlin-2 was selectively reduced in mutant
limbs (Fig. 6a). Immunohistochemical revealed that Kindlin-2
was essentially abolished in mutant chondrocytes (Fig. 6b). Limbs
and vertebrae were shorter and the ribcage was smaller in mutant
compared with WT mice (Fig. 6c–e). In contrast to Kindlin-2Prx1
cKO, mice lacking Kindlin-2 in chondrocytes did not exhibit any
E14.5
W
T
cK
O
E16.5 E18.5 P0
E14.5
E16.5
PZ
HZ
cKO
cK
O
3000
2500
2000
1500
Le
ng
th
 o
f P
O
C 
(m
)
1000
500
0
3000
2500
*
*
*
*
2000
1500
1000
500
0
E14.5 E16.5 E18.5
WT cKO WT cKO
P0
Co
nd
ro
cy
te
s/
m
m
2
E14.5 E16.5 E18.5 P0
*
*
*
WT
W
T
WT cKO WT cKO WT cKO WT cKO
E16.5 E18.5 P0
E14.5
400 μm
400 μm
400 μm
400 μm 400 μm
400 μm 400 μm
400 μm
E16.5 E18.5 P0
Figure 2 | Reduced cellularity and disrupted column formation in Kindlin-2Prx1 cKO. (a) Alcian blue stain of humeral sections from Cre-negative
Kindlin-2fl/fl (WT) and Kindlin-2Prx1 cKO (cKO) mice shows severe delay in POC formation in mutants. Original magnification: 40. Scale bar, 400 mm.
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proliferative zone (PZ) and the hypertrophic zone (HZ) of E16.5 WT and Kindlin-2Prx1 cKO humeri shows failure of column formation in mutants. Original
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marked abnormalities in skull vault and clavicle (Fig. 6c–e),
suggesting that intramembraneous ossification is unchanged in
the mutant. Similar to Kindlin-2Prx1 cKO, ablating Kindlin-2 in
chondrocytes disrupted column formation in long bones (Fig. 6f).
It should be noted that the reduction of chondrocyte density
in the long bone growth plate of Kindlin-2Col2a1 cKO was less
severe than in Kindlin-2Prx1 cKO (compare Fig. 2b with Fig. 6f).
Similar to Kindlin-2Prx1 cKO, deleting Kindlin-2 expression in
chondrocytes downregulated Sox9 mRNA without affecting the
expression of the adipogenic gene, Ap2 (adipocyte protein 2;
Fig. 6g). However, after birth, all Kindlin-2Col2a1 cKO mice (450)
rapidly developed growth retardation and severe dwarfism
(Fig. 6h,i). About 80% of the mice developed progressive
kyphosis and died within 1 month of birth because of
respiratory distress probably associated with compression of
cervical and thoracic vertebrae from the kyphosis (Fig. 6i,j).
Alcian blue staining of tibial sections showed delayed formation
of the secondary ossification centre (Fig. 6k) and reduced
subchondral bone (Fig. 6l) in mutants. Quantitative micro-
computerized tomography (mCT) analysis of 1-month-old femur
histomorphometric parameters showed that mutant mice have
dramatic reductions in both trabecular and cortical bones
(Fig. 6m-o). Collectively, these experiments establish that
Kindlin-2 expression in chondrocytes plays an intrinsic role in
the regulation of chondrocyte functions and chondrogenesis
during prenatal and postnatal skeletal development.
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Figure 4 | Kindlin-2 regulates Sox9 expression in chondrocytes. (a,b) In situ hybridization. E16.5 Cre-negative Kindlin-2fl/fl (WT) and Kindlin-2Prx1 cKO
(cKO) humeral (a) and forelimb digit (b) sections hybridized with antisense riboprobes for Sox9. Original magnification: 40. Scale bar, 400mm.
(c) Protein extracts from E16.5 WT and Kindlin-2Prx1 cKO forelimbs used for western blotting for Sox9 expression. (d) Primary mesenchymal progenitors
isolated from E13.5 Kindlin-2Prx1 cKO and WT limbs were differentiated for 4 days and analysed by qPCR for Sox9, Col2a1 and cadherin expression,
normalized to Gapdh mRNA. Experiments were repeated three times. *Po0.05, versus WT, Student’s t-test. Results were expressed as mean±s.d.
(e,f) ATDC5 chondrocytes were infected with equal amounts of adenoviral vectors for enhanced green fluorescent protein (Ad/EGFP) or Ad/Kindlin-2,
followed by western blotting (e) or qPCR analyses (f) for Sox9 expression. Experiments were repeated three times. *Po0.05, versus WT, Student’s t-test.
Results were expressed as mean±s.d. (g) COS-7 cells were co-transfected with p2.8Sox9-luc, pRL-SV40 (for normalization), and the indicated amounts
of pCMV/Kindlin-2 or pCMV/b-gal, followed by dual-luciferase assays. The amount of plasmid DNA was balanced as necessary with pCMV/b-gal such
that the total DNA was constant for each group. Experiments were repeated three times. *Po0.05 versus 0mg expression vectors, Student’s t-test.
(h) Primary chondrocytes from E13.5 WT ribcages stained with an anti-Kindlin-2 antibody or 40,6-diamidino-2-phenylindole, followed by fluorescence (IF)
microscopy for localization of Kindlin-2. Scale bar, 50mm. (i) Cytoplasmic (CE) and nuclear extracts (NE) from ATDC5 cells subjected to western blotting
for Kindlin-2 and tubulin (a cytoplasmic protein). (j–l) Primary mesenchymal progenitor cells isolated from E13.5 Kindlin-2Prx1 cKO and WT limbs were
infected with Ad/Sox9 or an equal amount of Ad/GFP. Four days later, the cells were cultured in the presence of 2 ngml 1 TGF-b1 for another 6 days,
followed by qPCR analyses for Col2a1 (J) and Runx2 (K), or alcian blue staining (L). mRNA levels were normalized to Gapdh mRNA. *Po0.05 (versus
WT/AdGFP or cKO/AdGFP, Student’s t-test). #Po0.05 (versus WT/AdGFP, Student’s t-test). Experiments were repeated in triplicates. Scale bar, 800 mm
(top), 160mm (bottom). Results were expressed as mean±s.d.
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Figure 5 | Kindlin-2 modulates TGF-b1 signalling during chondrocyte differentiation. (a) Protein extracts from E11.5–13.5 Cre-negative Kindlin-2fl/fl (WT)
and Kindlin-2Prx1 cKO (cKO) forelimbs were used for western blotting for the indicated proteins. (b) Immunohistochemistry. Sections of E12.5 WT and
Kindlin-2Prx1 cKO forelimbs stained with antibodies against pSmad2 antibody (top) or total Smad2/3 (bottom). Scale bar, 40mm. (c) Total RNA from E15.5
WTand Kindlin-2Prx1 cKO forelimbs were subjected to qPCR analysis for Tgf-b1 mRNA, which was normalized to Gapdh mRNA. Results were expressed as
mean±s.d. N¼4. (d) Primary cells isolated from E12.5 WT and Kindlin-2Prx1 cKO forelimbs were treated with or without 2 ngml 1 TGF-b1 for 30min,
followed by western blotting for the indicated proteins. (e) Quantitative data of pSmad2 from four independent experiments. *Po0.05 (versus no TGF-b1);
#Po0.05 (TGF-b1-induced fold increases of pSmad2 levels in cKO versus those in WT), Student’s t-test. Results were expressed as mean±s.d.
Experiments were repeated three times. (f,g) Primary mesenchymal progenitor cells isolated from E12.5 WTand Kindlin-2Prx1 cKO limbs were treated with
2 ngml 1 TGF-b1 for 7 days, followed by alcian blue staining for chondrogenic nodules (F) or qPCR analysis (G). *Po0.05 (versus no TGF-b1); #Po0.05
(TGF-b1-induced fold increases of mRNA levels in cKO versus those in WT), Student’s t-test. Experiments were repeated three times in triplicate. Scale bar,
800mm (top), 160mm (bottom). Results were expressed as mean±s.d. (h) b1 integrin activation. Primary mesenchymal progenitors isolated from E12.5
WTand Kindlin-2Prx1 cKO limbs were subjected to measurement of b1 integrin activation as described in Methods. Experiments were repeated three times
independently. *Po0.05 (versus WT), Student’s t-test. Results were expressed as mean±s.d.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8531
8 NATURE COMMUNICATIONS | 6:7531 | DOI: 10.1038/ncomms8531 | www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
Discussion
In the study reported here, we demonstrated that Kindlin-2
functions in skeletal development by controlling endonchondral
and intramembranous ossification processes. The severe skeletal
abnormalities and biochemical defects in chondrocytes and their
progenitors induced by the loss of Kindlin-2 suggest that Kindlin-
2 serves as a major controlling factor in the regulation of the
chondrocyte differentiation programme and chondrogenesis
during prenatal and postnatal skeletal development.
This study represents the first systematic investigation into the
functions of Kindlin-2 in chondrocyte differentiation and
chondrogenesis, processes that are of broad clinical importance.
The findings of our study can be summarized as follows. First,
Kindlin-2 controls chondrocyte proliferation by regulating, at
least in part, the expression of Ihh, a key factor for chondrocyte
proliferation. Second, Kindlin-2 protects chondrocytes from
apoptosis. Loss of Kindlin-2 greatly accelerates apoptosis of both
proliferative and hypertrophic chondrocytes. Reduced cell pro-
liferation and increased apoptosis contribute to reduced cellular-
ity in the growth plates in the mutant mice. Third, loss of
Kindlin-2 increases chondrocyte hypertrophy. Finally, Kindlin-2
is essential for chondrocyte column formation. Chondrocytes
lacking Kindlin-2 are scattered throughout the growth plates
rather than forming regular columns. Interestingly, deleting b1
integrin in chondrocytes in mice similarly disrupted column
formation in growth plates45. Reduced chondrocyte numbers and
disrupted chondrocyte organization together contribute to
decreased longitudinal growth of long bones and digits,
resulting in their shortening in mutants.
Importantly, we demonstrated that Kindlin-2 plays a critical
role in the regulation of TGF-b signalling. The loss of Kindlin-2
reduced Smad2 phosphorylation, a key downstream molecular
event of TGF-b signalling in limb chondrocytes in vivo. Of
particular significance, TGF-b-induced Smad2 phosphorylation,
chondrocyte differentiation gene expression, and chondrogenic
nodule formation were all dramatically reduced in primary
mesenchymal progenitor cells lacking Kindlin-2. These results
clearly demonstrate that Kindlin-2 is crucial to the control of
TGF-b signalling during the chondrogenic differentiation
programme. Interestingly, while this study was in progress,
Wei et al.46 reported that Kindlin-2 physically interacted with
TGFb R1 and activated Smad3 phosphorylation in human kidney
tubular epithelial cells. Furthermore, a more recent study showed
that Kindlin-1 controls TGF-b availability to regulate cutaneous
stem cell proliferation47. Detailed molecular mechanisms through
which Kindlin-2 modulates TGF-b signalling will be an
important area of future studies.
Several important lines of evidence from this study, and studies
by others, support the role of Kindlin-2 in regulating chondrocyte
function and chondrogenesis by controlling, at least in part, the
expression of Sox9, a master regulator of chondrocyte function.
First, we found that the loss of Kindlin-2 dramatically reduced
Sox9 expression at both the mRNA and protein levels in
chondrocytes, as well as in limbs. Second, in our study, the
overexpression of Kindlin-2 increased the levels of Sox9 mRNA
and protein and activated Sox9 gene promoter transcription.
Third, we found that the forced expression of Sox9 through
adenoviral vectors in primary mesenchymal progenitor cells
largely restored the defects in chondrocyte differentiation gene
expression and chondrogenic nodule formation induced by the
loss of Kindlin-2. Finally, mice lacking Kindlin-2 in Prx1-
expressing mesenchymal progenitors in the current study, and
those lacking Sox9 in the same cell type3 share some striking
cellular and skeletal abnormalities (for example, reduced
chondrocyte proliferation and survival, increased hypertrophy,
and severe limb shortening), suggesting that both factors may
function in the same pathway. The fact that Kindlin-2 protein
exists in the nuclei of chondrocytes and activates the Sox9 gene
promoter raises the possibility that Kindlin-2 may function as a
transcription activator or co-activator for the Sox9 gene, although
it is also possible that Kindlin-2 upregulates the expression of
some other protein(s) that in turn affect Sox9 expression. Future
study will elucidate these possibilities.
Work from this study, and studies by others, suggest that the
Kindlin-2-integrin signalling pathway plays an extremely impor-
tant role in chondrogenesis. The selective deletion of Kindlin-2 in
chondrocytes led to progressive dwarfism, severe kyphosis and
low bone mass in our study, while, in another study, inactivation
of b1 integrin in chondrocytes in mice resulted in a severe
chondrodysplasia45. ILK, a Kindlin-2-binding protein, regulated
chondrocyte shape and proliferation48 and mice lacking ILK in
chondrocytes displayed a similar chondrodysplasia49. However, it
is interesting to compare the phenotypes of the deletion of
Kindlin-2 in Prx1-expressing mesenchymal progenitor cells
(Prx1-Cre; Kindlin-2fl/fl mice) in the current study with those of
the deletion of b1 integrin (Prx1-Cre; b1fl/fl mice)50 in the same
cell type in mice. First, the skeletal defects exhibited by the
Prx1-Cre; Kindlin-2fl/fl mice were much more severe than those of
the Prx1-Cre; b1fl/fl mice. Prx1-Cre; Kindlin-2fl/fl mice died
immediately after birth while Prx1-Cre; b1fl/fl mice survived at
birth and beyond. Second, Prx1-Cre; Kindlin-2fl/fl mice displayed
severe defects in both intramembranous and endochondral
ossification, while no defects in intramembranous ossification
were reported in Prx1-Cre; b1fl/fl mice, although they did exhibit
less severe defects in endochondral ossification, including
shortened long bones. These findings suggest that Kindlin-2
controls intramembranous ossification independent of b1
integrin activation and/or a functional compensation of b3
integrin for the loss of b1 integrin in the head mesenchyme. Thus,
while the current study supports an important role of Kindlin-2
in regulation of the integrin signalling pathway in skeletal
development, it suggests that Kindlin-2 also plays pivotal roles in
the regulation of other major developmental pathways (for
example, Sox9 expression and TGF-b signalling) in the skeleton.
The genetic models and findings described in this paper will be
instrumental for future studies aimed at dissecting the integrin-
dependent and independent functions of Kindlin-2 during
different stages of skeletal development and homeostasis.
Methods
Generation of Kindlin-2fl/fl Mice. To generate Kindlin-2fl/fl mice, a Kindlin-2
targeting vector was generated as depicted in Supplementary Fig. 1a. This targeting
vector was linearized and introduced into R1 embryonic stem (ES) cells via elec-
troporation. G418-resistant ES cell clones were screened for homologous recombi-
nation by Southern blotting (Supplementary Fig.1b). Of 180 ES cell clones analysed,
10 had homologous recombination. Two of the ES cell clones were injected into
blastocysts from C57BL/6 mice, resulting in generation of chimeric mice, five of
which were almost 100% agouti males. We obtained germ-line transmission of the
floxed allele (Kindlin-2fl/þ þneo) by crossing the chimeric mice with C57BL/6
breeders. To avoid potential interference from the pGKneo cassette, we crossed the
mice with flippase deleter mice51 to generate floxed (without the neo cassette)
heterozygous mice (Kindlin-2fl/þ ). The Kindlin-2fl/þmice were intercrossed to
generate mice that are homozygous floxed (Kindlin-2fl/fl). Both heterozygous and
homozygous animals were viable and fertile and showed no noticeable phenotypic
changes. All mice used in this study have been crossed with normal C57BL/6 mice
for at least eight generations to minimize potential effects of genetic background on
skeletogenesis and homeostasis. All research protocols were approved by the
respective Institutional Animal Care and Use Committees (IACUC) of University of
Pittsburgh, University of California, San Diego or Rush University.
Bone histology and immunohistochemistry. Embryos and neonates were stained
with alcian blue and alizarin red as previously described52. In brief, embryos and
neonates were eviscerated and fixed in 100% ethanol for 4 days and transferred to
acetone. After 3 days, they were rinsed with water and stained for 10 days in
staining solution containing 1 vol 0.1% alizarin red S (Sigma, St. Louis, MO) in 95%
ethanol, 1 vol 0.3% alcian blue 8GX (Sigma) in 70% ethanol, 1 vol 100% acetic acid
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and 17 vol ethanol. After rinsing with 95% ethanol, specimens were kept in 20%
glycerol/1% KOH at 37 C for 24 h and then at room temperature until the
skeletons became clearly visible. For storage, specimens were transferred into 50%,
80%, and finally, 100% glycerol. For histology, bone tissues were fixed in 10%
formalin at 4 C for 24 h, decalcified in 10% EDTA (pH 7.4) for 10–14 days and
embedded in paraffin. Bone sections were used for haematoxylin and alcian blue
staining using our standard protocols. Fixed non-demineralized femurs were used
for microcomputerized tomography (mCT) analysis in the Department of
Biochemistry of Rush University Medical Center using a mCT35 (SCANCO
Medical AG), as previously described53. Following killing, femurs were isolated and
fixed in 70% ethanol for 2 days. Non-demineralized femurs from each group were
scanned and measured by mCT (mCT35, SCANCO Medical AG, Wayne, PA) with
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an isotropic resolution of 7.0 mm, following the standards of techniques and
terminology recommended by the American Society for Bone and Mineral
Research54. For trabecular bone parameters, transverse slices were obtained in the
region of interest in the axial direction from the trabecular bone 0.1mm below the
growth plate (bottom of the primary spongiosa). Contours were defined and drawn
close to the cortical bone. The trabecular bone was then removed and analysed
separately. A three-dimensional analysis was performed on 250 trabecular bone
slices. A 1.75-mm section was used to obtain mid-femoral cortical bone thickness.
The analysis of the specimens involved the following bone measurements—bone
volume fraction/total tissue volume (%) and cortical thickness (Cort.Th). For
immunohistochemistry, 5-mm sections were stained with antibodies against
Kindlin-2 (Abcam, cat#: ab74030, 1:400), active caspase-3 (Abcam, cat# ab2302,
1:300), pSmad2 (Cell Signaling Technology, cat#: 8828S, 1:300), total Smad2/3
(Cell Signaling Technology, cat#: 8685S, 1:500) or control IgG using the
EnVisionþSystem-HRP (DAB) kit (Dako North America Inc.) according to the
manufacturer’s instruction.
Immunofluorescence and confocal analysis. Cells were seeded and cultured on
sterile glass cover slips in six-well plates. Twenty-four hours later, cells were fixed
in 10% formaldehyde for 30min at 37 C. Cells were permeabilized with 0.2%
Triton-X-100 containing 40 ,6-diamidino-2-phenylindole for 5min, and blocked
with 2% bovine serum albumin for 1 h. The cells were then stained with a primary
antibody (mouse anti-Kindlin-2, diluted 1:300) overnight at 4 C. After washing,
the cells were incubated with anti-mouse Alexa Fluor 594 (Invitrogen) secondary
antibodies (1:300) for 1 h at room temperature. Cells were then imaged using a
confocal microscope (SP2-AOBS Leica Microsystems).
In vivo cell proliferation and TUNEL staining. BrdU staining was used to
measure cell proliferation as previously described55. In brief, pregnant mice (E14.5)
were injected intraperitoneally with 100mg bromodeoxyuridine (BrdU)/12 mg
fluorodeoxyuridine per gram of body weight 3 h before killing. After killing,
embryos were removed and genotyped. Humeri of WT and Kindlin-2Prx1 cKO
mice were isolated and sectioned at 10 mm. To identify actively proliferating
chondrocytes, nuclei that have incorporated BrdU were detected using a
Zymed BrdU immunostaining kit according to the manufacturer’s instruction.
BrdU-positive cells were counted and normalized to the total cell numbers in the
same area. Cell survival was evaluated using the ApopTag Peroxidase In Situ
Apoptosis Detection Kit (Millipore) as previously described56,57. This method is
based on the classical TUNEL assay to examine apoptosis by detecting DNA
fragmentation. Sections of WT and Kindlin-2Prx1 cKO humeri were prepared and
stained using the kit according to the manufacturer’s instruction. Cells were
counterstained with haematoxylin. All positive (brown) and negative (blue) nuclei
were counted. Apoptotic cells were normalized to the total cells from the same area.
qPCR and western blot and in situ hybridization. RNA isolation and reverse
transcription (RT) have been previously described58. In brief, total RNAs were
isolated using the Trizol reagent (Invitrogen) following the manufacturer’s
protocol. RT was performed using 1 mg of denatured RNA and 100 pmol of random
hexamers (Applied Biosystem, Foster, CA) in a total volume of 25 ml containing
12.5U MultiScribe reverse transcriptase (Applied Biosystem). Quantitative
real-time RT-PCR (qPCR) analysis was performed to measure the relative mRNA
levels using the SYBR Green kit (Bio-Rad Laboratories Inc.). Samples were
normalized to Gapdh expression. The DNA sequences of primers used for qPCR
are summarized in Supplementary Table 1. Western blot analysis was performed as
previously described59. In brief, protein extracts were fractionated on a 10%
SDS–polyacrylamide gel electrophoresis gel and transferred onto nitrocellulose
membranes (Schleicher & Schuell, Keene, NH). The membrane was blocked in 5%
non-fat milk in Tris-buffered saline/Tween 20 buffer; probed with primary
antibodies, followed by incubation with secondary antibodies conjugated with
horseradish peroxidase; and visualized using a Western Blotting Detection Kit
(GE Healthcare, cat#: RPN2106). Antibodies used for western blotting in this study
were Kindlin-1 (Sigma, SAB4200465, 1:1,000), Kindlin-3 (Cell Signaling, Cat#
13,843, 1:300), TGFb R1 (Santa Cruz, sc-9048, 1:500), TGFb R2 (Santa Cruz,
sc-400, 1:500), pFAK (Santa Cruz, sc-11765, 1:300), Sox9 (Santa Cruz
Biotechnology, sc-20095, 1:500), pSmad2/3 (Cell Signaling Technology, cat#:
8828S, 1:500), total Smad2/3 (Cell Signaling Technology, cat#: 8685S, 1:500),
integrin b1 (BD, cat# 610468, 1:3,000), ILK (Cell Signaling, cat# I0783, 1:1,000),
p38 MAPK (Cell Signaling, cat# 9,212, 1:1,000), phospho-p38 MAPK (Cell
Signaling, cat# 9,216, 1:1,000), (Sigma-Aldrich, cat#: T-7451, 1:1,000), tubulin
(Sigma-Aldrich, cat#: T-7451, 1:5,000), b-actin (Sigma-Aldrich, cat#: A5316,
1:4,000). The Kindlin-2 antibody (1:1,000) has been previously described19.
Secondary anti-rabbit (1:5,000) or anti-mouse (1:5,000) antibodies conjugated with
horseradish peroxidase were from Santa Cruz Biotechnology Inc. Images of
western blots are provided as Supplementary Figs 8 and 9. Five-mm bone sections
were mounted onto polylysine-treated slides and subjected to in situ hybridization
using a protocol provided by the Center for Musculoskeletal Research, University
of Rochester (http://www.urmc.rochester.edu/musculoskeletal-research/core-
services/histology/protocols.cfm). The vectors for preparing the Sox9 and Ihh
probes were kindly provided by Dr Matthew J. Hilton (University of Rochester
Medical Center). Antisense riboprobe syntheses were prepared using the DIG RNA
Labeling Mix from Roche (Cat#: 11277073910).
DNA constructs and transfection and infection. pCMV/b-gal and pCMV/
Kindlin-2 were previously described19. p2.8Sox9-luc was kindly provided by
Professor Elazar Zelzer of the Weizmann Institute of Science. For transfection, the
cells were plated on 35-mm dishes at a density of 5 104 cells cm 2. After 24 h, the
cells were transfected with LipofectAMINE 2,000 (Invitrogen) according to the
manufacturer’s instructions. Each transfection contained 0.25mg of the indicated
reporter plasmids plus 1 ng of pRL-SV40, containing a complementary DNA for
Renilla Reformis luciferase to control for transfection efficiency. The cells were
harvested and assayed using the Dual Luciferase Assay Kit (Promega, Madison, WI)
on a Module Microplate Multimode Reader (Turner Biosystem, Sunnyvale, CA). For
all transfection experiments, the amount of plasmid DNA was balanced as necessary
with pCMV/b-gal such that the total DNA was constant for each group. Adenoviral
vectors for enhanced green fluorescent protein (Ad/EGFP) and Kindlin-2 (Ad/
Kindlin-2) were previously described20. Ad/Cre was kindly provided by Dr Yifan Dai
of the Nanjing Medical University. Ad/Sox9 was purchased from Vector BioLabs
(Philadelphia, PA). Cells were infected with adenovirus as previously described58. In
briefly, virus was added to cells in 1% fetal bovine serum (FBS) and incubated for 1 h
at 37 C. Dishes were rotated every 5min for the first 15min to ensure that all of the
cells were exposed to virus. After 1 h, media were aspirated, and cultures were rinsed
twice with serum-free medium, and then fresh media supplemented with 10% FBS
were added to the dishes. The amount of adenovirus was balanced as necessary with
Ad/EGFP such that the total amount was constant in each group.
Isolation of limb MSCs and micromass culture. Isolation of limb mesenchymal
cells was performed as previously described11. In brief, limb buds from E12.5 or
E13.5 embryos were isolated, dissociated into single cell suspension by digesting
with 1mgml 1 collagenase D (Roche Applied Sci., Cat# 11088858001) for 3 h in a
37-C incubator and filtered to remove undigested tissues. The cells were pelleted
by centrifugation at 1,000 r.p.m. for 5min, resuspended and reconstituted at a
density of 1 107 cellsml 1 in F12:DMEM (1:1) media supplemented with 10%
FBS and antibiotics. For micromass cultures, 1 105 cells in 10 ml were dropped
into a dish and allowed to attach for 1 h in a 37-C incubator. The cells were then
flooded with the F12:DMEM (1:1) media supplemented with 10% FBS and
antibiotics, 50 mgml 1 ascorbic acid and 10mM b-glycerol phosphate for the
indicated times, followed by alcian blue staining, western blot or qPCR analyses.
Figure 6 | Deleting Kindlin-2 in chondrocytes causes multiple severe skeletal defects. (a) Protein extracts were isolated from the indicated tissues of P0
Cre-negative Kindlin-2fl/fl (WT) and Kindlin-2Col2a1 cKO (cKO) mice, followed by western blot analysis for Kindlin-2 expression. b-Actin was used as a
loading control. FL, forelimb; HL, hindlimb. (b) Immunohistochemistry. Sections of P0 WT and Kindlin-2Col2a1 cKO humeri stained with anti-Kindlin-2
antibody or normal IgG. Scale bar, 40mm. (c) Alizarin red and alcian blue double stain of P0 WT and Kindlin-2Col2a1 cKO skeletons. Scale bar, 1 cm.
(d) Calvaria, limb, sternum and clavicle from P0 WT and Kindlin-2Col2a1 cKO embryos. (e) Quantitation of P0 bone length. N¼4, *Po0.05, versus WT,
Student’s t-test. Scale bar, 1 cm. (f) Alcian blue stain of P0 humeral sections. Representative images of proliferative (PZ) and hypertrophic zone (HZ)
chondrocytes show disrupted column formation in mutants. Original magnification, 400. Scale bar, 40mm. (g) Primary chondrocytes isolated from P3
ribcages of Kindlin-2Col2a1 cKO and WT were differentiated with 2 ngml 1 TGF-b1 for 7 days, followed by qPCR analysis for Sox9 and Ap2 expression
normalized to Gapdh mRNA. (h) Animal growth curves. N¼4, *Po0.05, versus WT, Student’s t-test. Results were expressed as mean±s.d. (i) Gross
appearance of P20 Kindlin-2Col2a1cKO and WTmice shows severe dwarfism and kyphosis. Scale bar, 1 cm. (j) Alizarin red and alcian blue double staining of
P20 skeletons reveals reduced skeleton size and severe kyphosis in mutants. Scale bar, 1 cm. (k,l) Alcian blue stain of P17 (K) and P30 (L) tibial sections
show delayed formation of the secondary ossification center and reduced subchondral bone in mutants. Scale bar, 400mm. (m) Three-dimensional
reconstruction from microcomputerized tomography (mCT) scans of femurs from 1-month-old female mice of the two genotypes. Scale bar, 100mm.
(n,o) Quantitative analyses of bone volume/tissue volume (BV/TV) and cortical bone thickness (Cort.Th) from L. *Po0.05 (versus WT), Student’s t-test,
N¼4. Results were expressed as mean±s.d.
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Measurement of b1 integrin activation. Integrin activation was analysed based
on a protocol that we have previously described60. In brief, active b1 integrin was
detected by incubating the mesenchymal cells isolated from WT and Kindlin-2Prx1
cKO limbs with a rat anti-b1 integrin antibody (9EG7) that specifically recognizes
the active form of b1 integrin (BD Pharmingen). The cells were washed three times
with PBS containing 5mgml 1 bovine serum albumin and then incubated with
FITC-conjugated anti-rat IgG at 4 C for 30min. Total b1 integrin was detected by
incubating the cells with Alexa Fluor 647-conjugated anti-b1 integrin antibody that
recognizes total b1 integrin (BioLegend catalogue number 102,214) at 4 C for
30min. The levels of the active and total b1 integrin were quantified using a BD
FACS Calibur flow cytometer. The integrin activation index is defined as the mean
fluorescence intensities of active b1 integrin divided by the mean fluorescence
intensities of b1 integrin. The effect of loss of Kindlin-2 on b1 integrin activation
was assessed by comparing the activation index in mutant cells with that of
Cre-negative (WT) cells (normalized to 100%).
Statistical analysis. The data were analysed using the GraphPad Prism software
(4.0). Student’s’ t-test was used to test for differences between two groups of data.
Results were expressed as mean±s.d. Differences with Po0.05 were considered
statistically significant. All experiments were repeated at least three times.
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